NBY- Novabay Pharmaceuticals, Inc.

Name: Novabay Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Novabay Pharmaceuticals, Inc. (NBY) has 4 insiders with recent SEC Form 4 filings, including 8 buys and 3 sells. NBY is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	R01 Fund LP	56.81M	$110.77M	-
10%	Framework Ventures IV L.P.	56.81M	$110.77M	-
10%	Lazar David E.	6.39M	$12.46M	-
CEO	Kazley Michael John	4.12M	$8.03M	-

Activity

Buys and sells only

Transactions

10 filings · page 2

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Nov 21, 2022	Kunin Jeffrey	President, Dermadoctor, LLC	Sell	5,960	$2.10	$12,545.20	-100%	+0.4%	-86.0%
Sep 14, 2022	Kunin Jeffrey	President, Dermadoctor, LLC	Sell	291,368	$0.16	$46,094.42	-58.3%	-70.7%	-90.7%
Sep 14, 2022	Kunin Audrey	Chief Product Officer	Sell	291,368	$0.16	$46,094.42	-58.3%	-70.7%	-90.7%
Sep 14, 2022	Hall Justin	CEO, GC And Director	Buy	10,000	$0.15	$1,500.00	+13.7%	-70.7%	-90.7%
Dec 6, 2021	Hall Justin	CEO, GC And Director	Buy	69,767	$0.43	$29,999.81	+2,049%	-37.6%	-87.9%
Dec 6, 2021	Jones Andrew D.	CFO	Buy	45,455	$0.44	$20,000.20	+26.3%	-37.6%	-87.9%
Dec 3, 2021	Kunin Jeffrey	President, Dermadoctor, LLC	Buy	101,650	$0.46	$47,013.13	+25.5%	-32.2%	-86.6%
Dec 3, 2021	Kunin Audrey	Chief Product Officer	Buy	101,650	$0.46	$47,013.13	+25.5%	-32.2%	-86.6%
Dec 2, 2021	Kunin Jeffrey	President, Dermadoctor, LLC	Buy	262,369	$0.48	$124,887.64	+192.9%	-36.2%	-87.4%
Dec 2, 2021	Kunin Audrey	Chief Product Officer	Buy	262,369	$0.48	$124,887.64	+192.9%	-36.2%	-87.4%

← PrevPage 2Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC